The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback